Larval debridement therapy: diabetic foot ulcer management

Share this article

Larval debridement therapy: diabetic foot ulcer management

1 January 2014

Larval therapy is well established as a highly-selective method of both debriding and treating diabetic foot ulcers. Evidence now demonstrates that this method is safe, efficient and cost-effective. This document provides a practical guide to the use of larval therapy in diabetic foot ulcer management.

Larval therapy can be used as part of an integrated care plan involving effective pressure relief/offloading, infection control, revascularisation, glycaemic control and patient education. Debridement helps to reduce the rate of infection and provides an ideal healing environment. Potentially all patients with a neuropathic foot ulcer are suitable candidates where there is an overall clinical decision for rapid debridement of devitalised tissue. Wounds most suited to larval theapy include moist/sloughy/necrotic wounds.

To read more, download the pdf

This document has been supported by BioMonde
 

Free for all healthcare professionals

Sign up to the Wounds Group journals





By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.